These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10534214)

  • 1. Factors influencing the incidence of lamotrigine-related skin rash.
    Wong IC; Mawer GE; Sander JW
    Ann Pharmacother; 1999 Oct; 33(10):1037-42. PubMed ID: 10534214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of dermatologic precautions on the incidence of rash with addition of lamotrigine in the treatment of bipolar I disorder: a randomized trial.
    Ketter TA; Greist JH; Graham JA; Roberts JN; Thompson TR; Nanry KP
    J Clin Psychiatry; 2006 Mar; 67(3):400-6. PubMed ID: 16649826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Lamotrigine-associated rash.
    Hirsch LJ; Weintraub DB; Buchsbaum R; Spencer HT; Straka T; Hager M; Resor SR
    Epilepsia; 2006 Feb; 47(2):318-22. PubMed ID: 16499755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful re-introduction of lamotrigine after initial rash.
    Besag FM; Ng GY; Pool F
    Seizure; 2000 Jun; 9(4):282-6. PubMed ID: 10880290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamotrigine-associated rash: to rechallenge or not to rechallenge?
    Lorberg B; Youssef NA; Bhagwagar Z
    Int J Neuropsychopharmacol; 2009 Mar; 12(2):257-65. PubMed ID: 18845017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lamotrigine-associated rash: risk/benefit considerations in adults and children.
    Guberman AH; Besag FM; Brodie MJ; Dooley JM; Duchowny MS; Pellock JM; Richens A; Stern RS; Trevathan E
    Epilepsia; 1999 Jul; 40(7):985-91. PubMed ID: 10403224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash.
    Ketter TA; Wang PW; Chandler RA; Alarcon AM; Becker OV; Nowakowska C; O'Keeffe CM; Schumacher MR
    J Clin Psychiatry; 2005 May; 66(5):642-5. PubMed ID: 15889953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of lamotrigine and the new antiepileptic drugs: the challenge.
    Pellock JM
    J Child Neurol; 1997 Nov; 12 Suppl 1():S48-52. PubMed ID: 9429131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trial.
    Woo YS; Bahk WM; Jon DI; Joo YH; Kim W; Seo JS; Ahn YM; Chung SK; Won SH; Shin YC; Yoon BH; Jung SH; Seok JH; Lee YS; Kim Y; Min KJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1147-52. PubMed ID: 19540298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine-induced rash--worth a rechallenge.
    P-Codrea Tigaran S; Sidenius P; Dam M
    Acta Neurol Scand; 2005 Mar; 111(3):191-4. PubMed ID: 15736314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Children versus adults: pharmacokinetic and adverse-effect differences.
    Anderson GD
    Epilepsia; 2002; 43 Suppl 3():53-9. PubMed ID: 12060006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis.
    Wang XQ; Xiong J; Xu WH; Yu SY; Huang XS; Zhang JT; Tian CL; Huang DH; Jia WQ; Lang SY
    Seizure; 2015 Feb; 25():52-61. PubMed ID: 25645637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rash with lamotrigine: dosing guidelines.
    Messenheimer JA; Guberman AH
    Epilepsia; 2000 Apr; 41(4):488. PubMed ID: 10756418
    [No Abstract]   [Full Text] [Related]  

  • 14. Rechallenge with lamotrigine after initial rash.
    Tavernor SJ; Wong IC; Newton R; Brown SW
    Seizure; 1995 Mar; 4(1):67-71. PubMed ID: 7788112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic skin rash with lamotrigine and concomitant valproate therapy: evidence for an increased risk.
    Li LM; Russo M; O'Donoghue MF; Duncan JS; Sander JW
    Arq Neuropsiquiatr; 1996 Mar; 54(1):47-9. PubMed ID: 8736144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.
    Biton V
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):1009-18. PubMed ID: 17125413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of long-term lamotrigine in epilepsy.
    Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety review of adult clinical trial experience with lamotrigine.
    Messenheimer J; Mullens EL; Giorgi L; Young F
    Drug Saf; 1998 Apr; 18(4):281-96. PubMed ID: 9565739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine.
    Matsuo F
    Epilepsia; 1999; 40 Suppl 5():S30-6. PubMed ID: 10530692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.